181 related articles for article (PubMed ID: 19336785)
1. Treated depression in adolescents: predictors of outcome at 28 weeks.
Wilkinson P; Dubicka B; Kelvin R; Roberts C; Goodyer I
Br J Psychiatry; 2009 Apr; 194(4):334-41. PubMed ID: 19336785
[TBL] [Abstract][Full Text] [Related]
2. Selective serotonin reuptake inhibitors (SSRIs) and routine specialist care with and without cognitive behaviour therapy in adolescents with major depression: randomised controlled trial.
Goodyer I; Dubicka B; Wilkinson P; Kelvin R; Roberts C; Byford S; Breen S; Ford C; Barrett B; Leech A; Rothwell J; White L; Harrington R
BMJ; 2007 Jul; 335(7611):142. PubMed ID: 17556431
[TBL] [Abstract][Full Text] [Related]
3. A randomised controlled trial of cognitive behaviour therapy in adolescents with major depression treated by selective serotonin reuptake inhibitors. The ADAPT trial.
Goodyer IM; Dubicka B; Wilkinson P; Kelvin R; Roberts C; Byford S; Breen S; Ford C; Barrett B; Leech A; Rothwell J; White L; Harrington R
Health Technol Assess; 2008 May; 12(14):iii-iv, ix-60. PubMed ID: 18462573
[TBL] [Abstract][Full Text] [Related]
4. Combined treatment with cognitive-behavioural therapy in adolescent depression: meta-analysis.
Dubicka B; Elvins R; Roberts C; Chick G; Wilkinson P; Goodyer IM
Br J Psychiatry; 2010 Dec; 197(6):433-40. PubMed ID: 21119148
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness of selective serotonin reuptake inhibitors and routine specialist care with and without cognitive behavioural therapy in adolescents with major depression.
Byford S; Barrett B; Roberts C; Wilkinson P; Dubicka B; Kelvin RG; White L; Ford C; Breen S; Goodyer I
Br J Psychiatry; 2007 Dec; 191():521-7. PubMed ID: 18055956
[TBL] [Abstract][Full Text] [Related]
6. Long-term outcome of adolescent depression initially resistant to selective serotonin reuptake inhibitor treatment: a follow-up study of the TORDIA sample.
Vitiello B; Emslie G; Clarke G; Wagner KD; Asarnow JR; Keller MB; Birmaher B; Ryan ND; Kennard B; Mayes TL; DeBar L; Lynch F; Dickerson J; Strober M; Suddath R; McCracken JT; Spirito A; Onorato M; Zelazny J; Porta G; Iyengar S; Brent DA
J Clin Psychiatry; 2011 Mar; 72(3):388-96. PubMed ID: 21208583
[TBL] [Abstract][Full Text] [Related]
7. Clinical and psychosocial predictors of suicide attempts and nonsuicidal self-injury in the Adolescent Depression Antidepressants and Psychotherapy Trial (ADAPT).
Wilkinson P; Kelvin R; Roberts C; Dubicka B; Goodyer I
Am J Psychiatry; 2011 May; 168(5):495-501. PubMed ID: 21285141
[TBL] [Abstract][Full Text] [Related]
8. Antidepressants for people with epilepsy and depression.
Maguire MJ; Marson AG; Nevitt SJ
Cochrane Database Syst Rev; 2021 Apr; 4(4):CD010682. PubMed ID: 33860531
[TBL] [Abstract][Full Text] [Related]
9. Treatment of Resistant Depression in Adolescents (TORDIA): week 24 outcomes.
Emslie GJ; Mayes T; Porta G; Vitiello B; Clarke G; Wagner KD; Asarnow JR; Spirito A; Birmaher B; Ryan N; Kennard B; DeBar L; McCracken J; Strober M; Onorato M; Zelazny J; Keller M; Iyengar S; Brent D
Am J Psychiatry; 2010 Jul; 167(7):782-91. PubMed ID: 20478877
[TBL] [Abstract][Full Text] [Related]
10. Cognitive-behavioural therapy and short-term psychoanalytic psychotherapy versus brief psychosocial intervention in adolescents with unipolar major depression (IMPACT): a multicentre, pragmatic, observer-blind, randomised controlled trial.
Goodyer IM; Reynolds S; Barrett B; Byford S; Dubicka B; Hill J; Holland F; Kelvin R; Midgley N; Roberts C; Senior R; Target M; Widmer B; Wilkinson P; Fonagy P
Health Technol Assess; 2017 Mar; 21(12):1-94. PubMed ID: 28394249
[TBL] [Abstract][Full Text] [Related]
11. New generation antidepressants for depression in children and adolescents: a network meta-analysis.
Hetrick SE; McKenzie JE; Bailey AP; Sharma V; Moller CI; Badcock PB; Cox GR; Merry SN; Meader N
Cochrane Database Syst Rev; 2021 May; 5(5):CD013674. PubMed ID: 34029378
[TBL] [Abstract][Full Text] [Related]
12. Pharmacotherapy of major depressive disorder in adolescents.
Masi G; Liboni F; Brovedani P
Expert Opin Pharmacother; 2010 Feb; 11(3):375-86. PubMed ID: 20102303
[TBL] [Abstract][Full Text] [Related]
13. Predictors associated with improved cognitive-behavioral therapy outcome in pediatric obsessive-compulsive disorder.
Torp NC; Dahl K; Skarphedinsson G; Compton S; Thomsen PH; Weidle B; Hybel K; Valderhaug R; Melin K; Nissen JB; Ivarsson T
J Am Acad Child Adolesc Psychiatry; 2015 Mar; 54(3):200-207.e1. PubMed ID: 25721185
[TBL] [Abstract][Full Text] [Related]
14. Management of treatment-resistant depression in children and adolescents.
DeFilippis M; Wagner KD
Paediatr Drugs; 2014 Oct; 16(5):353-61. PubMed ID: 25200567
[TBL] [Abstract][Full Text] [Related]
15. Child and adolescent depression intervention overview: what works, for whom and how well?
Maalouf FT; Brent DA
Child Adolesc Psychiatr Clin N Am; 2012 Apr; 21(2):299-312, viii. PubMed ID: 22537728
[TBL] [Abstract][Full Text] [Related]
16. The Treatment for Adolescents With Depression Study (TADS): long-term effectiveness and safety outcomes.
March JS; Silva S; Petrycki S; Curry J; Wells K; Fairbank J; Burns B; Domino M; McNulty S; Vitiello B; Severe J
Arch Gen Psychiatry; 2007 Oct; 64(10):1132-43. PubMed ID: 17909125
[TBL] [Abstract][Full Text] [Related]
17. Meaning and medication: a thematic analysis of depressed adolescents' views and experiences of SSRI antidepressants alongside psychological therapies.
Maroun RA; Thackeray LA; Midgley N
BMC Psychiatry; 2018 Nov; 18(1):374. PubMed ID: 30486802
[TBL] [Abstract][Full Text] [Related]
18. Symptom clusters in adolescent depression and differential response to treatment: a secondary analysis of the Treatment for Adolescents with Depression Study randomised trial.
Bondar J; Caye A; Chekroud AM; Kieling C
Lancet Psychiatry; 2020 Apr; 7(4):337-343. PubMed ID: 32199509
[TBL] [Abstract][Full Text] [Related]
19. A randomised controlled trial to compare the cost-effectiveness of tricyclic antidepressants, selective serotonin reuptake inhibitors and lofepramine.
Peveler R; Kendrick T; Buxton M; Longworth L; Baldwin D; Moore M; Chatwin J; Goddard J; Thornett A; Smith H; Campbell M; Thompson C
Health Technol Assess; 2005 May; 9(16):1-134, iii. PubMed ID: 15876362
[TBL] [Abstract][Full Text] [Related]
20. Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial.
March J; Silva S; Petrycki S; Curry J; Wells K; Fairbank J; Burns B; Domino M; McNulty S; Vitiello B; Severe J;
JAMA; 2004 Aug; 292(7):807-20. PubMed ID: 15315995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
